Similar articles

• Compared response to chloroquine, fansidar, quinine, and quinidine slow release of infections with Plasmodium falciparum in the Kivu region of Zaire.

  Delacollette C, Cibanguka J, Buregea H, Nkera J. Delacollette C, et al. Acta Leiden. 1987;55:159-62. Acta Leiden. 1987. PMID: 3321832 No abstract available.
• Fansidar-resistant Plasmodium falciparum infection from Tanzania.

  Vleugels MP, Wetsteyn JC, Meuwissen JH. Vleugels MP, et al. Trop Geogr Med. 1982;34(3):263-5. Trop Geogr Med. 1982. PMID: 6758246
• [Uncomplicated malaria attack in an area with high resistance to chloroquine. 3. The use of second-choice oral drug treatment].

  Hengy C, Eberlé F, Gazin P, Kouka-Bemba D, Gelas H, Jambou R. Hengy C, et al. Bull Soc Pathol Exot. 1990;83(1):61-5. Bull Soc Pathol Exot. 1990. PMID: 2190706 French.
• Falciparum malaria: the urgent need for safe and effective drugs.

  Rieckmann KH. Rieckmann KH. Annu Rev Med. 1983;34:321-35. doi: 10.1146/annurev.me.34.020183.001541. Annu Rev Med. 1983. PMID: 6344762 Review.
• Extension of multiple drug resistant Plasmodium falciparum malaria in Africa: report of a Central African case.

  Belec L, Bouree P, Testa J, Delmont J, Quenum B, Georges AJ. Belec L, et al. Biomed Pharmacother. 1989;43(9):699-702. doi: 10.1016/0753-3322(89)90090-5. Biomed Pharmacother. 1989. PMID: 2696567 Review.